Halo Biomedical LP - Net Worth and Insider Trading
Halo Biomedical LP Net Worth
The estimated net worth of Halo Biomedical LP is at least $102 Million dollars as of 2025-03-27. Halo Biomedical LP is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 18,000,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $102 Million. Details can be seen in Halo Biomedical LP's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Halo Biomedical LP has not made any transactions after 2023-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Halo Biomedical LP
Halo Biomedical LP Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Halo Biomedical LP owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Click here to see the complete history of Halo Biomedical LP’s form 4 insider trades.
Insider Ownership Summary of Halo Biomedical LP
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 2201 Interest of corporation controlled by you |
Halo Biomedical LP Latest Holdings Summary
Halo Biomedical LP currently owns a total of 1 stock. Halo Biomedical LP owns 18,000,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $102 Million.
Latest Holdings of Halo Biomedical LP
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 18,000,000 | 5.66 | 101,880,000 |
Holding Weightings of Halo Biomedical LP
Halo Biomedical LP Form 4 Trading Tracker
According to the SEC Form 4 filings, Halo Biomedical LP has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 18,000,000 shares on September 5, 2023, which brought Halo Biomedical LP around $0.
Insider Trading History of Halo Biomedical LP
- 1
Halo Biomedical LP Trading Performance
Halo Biomedical LP Ownership Network
Ownership Network List of Halo Biomedical LP
Ownership Network Relation of Halo Biomedical LP
Halo Biomedical LP Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
Halo Biomedical LP is the 2201 Interest of corporation controlled by you of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include 2501 Other Tian Wenzhi , 2201 Interest of corporation controlled by you Yu Xiaoyong , and 2101 Beneficial owner shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, Halo Biomedical LP made no insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541). Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 3,165,000 shares made by shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo , a net sale of 0 shares made by Tian Wenzhi , and a net sale of 0 shares made by shang hai zhang jiang ke ji chuang ye tou zi you xian gong si .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,165,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,165,000 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
Halo Biomedical LP Mailing Address
Above is the net worth, insider trading, and ownership report for Halo Biomedical LP. Currently GuruFocus does not have mailing address information for Halo Biomedical LP.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
